Status:
COMPLETED
Vitamin B12 Acceptance and Biomarker Response Study
Lead Sponsor:
University Hospital, Basel, Switzerland
Collaborating Sponsors:
University of Basel
Aarelab AG
Conditions:
Vitamin B 12 Deficiency
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
In this study, biomarker response after supplementation with oral and intramuscular vitamin B12 will be compared in a randomized clinical trial. Electronic compliance monitoring will be used to contro...
Eligibility Criteria
Inclusion
- General practitioner's prescription for Vitamin B12 deficiency testing
- Age\> 18 years
- Ability to give written informed consent
- Vitamin B12 serum concentrations \< 200pmol/l
- indication for vitamin B12 supplementation according to the General practitioners estimation
Exclusion
- Patients with incorrect intake of vitamin preparations containing vitamin B12
- Patients with previously diagnosed dementia
- Patients with known hereditary transcobalamin transportation defects
- lack of written and/or oral understanding in German, French, Italian or English languages
Key Trial Info
Start Date :
May 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2015
Estimated Enrollment :
37 Patients enrolled
Trial Details
Trial ID
NCT01832129
Start Date
May 1 2013
End Date
December 1 2015
Last Update
June 14 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pharmaceutical Care Research Group
Basel, Basel, Switzerland, CH-4056